Back to Agenda
Session 6: Communication Channels for QPPVs
Session Chair(s)
Peter De Veene, MD
GQPPV
MSD Belgium, Belgium
Nicolas Tsiakkas, MD
Scientific Director
NIKOLAS TSIAKKAS AND CO OE, Greece
Access to timely information is critical for the EU QPPV to fullfill their role of providing patients and prescribers with the most relevant data. This happens in collaboration with internal and external stakeholders. Currently the QPPV has access to several data sources and at the same time the QPPV receives regular communications from the EMA (signals, QPPV Update) and other competent authorities. This session will explore the different communication channels the EU QPPV has access to and to assist the discussion, attendees and QPPVs will be asked to fill in a survey covering the different types of communications.
Speaker(s)
Feedback from the Communication Channels Survey
Zurab Koberidze, MD, PhD, MPH
FGK Pharmacovigilance Gmbh, Germany
Director Pharmacovigilance
Incoming communications from regulators and how they are being assessed and distributed internally by the QPPV office
Naomi Morris, MS
Pfizer Srl., Italy
Head of QPPV Compliance Office
Communication on Safety Information: Regional and Local Case Study
Nicolas Tsiakkas, MD
NIKOLAS TSIAKKAS AND CO OE, Greece
Scientific Director
Have an account?